Rebooting the Adaptive Immune Response in Immunotherapy‐Resistant Lung Adenocarcinoma Using a Supramolecular Albumin

Fanni Li(First Affiliated Hospital of Xi'an Jiaotong University), Wangxiao He(First Affiliated Hospital of Xi'an Jiaotong University), Jingmei Wang(Fudan University), Jin Yan(Second Affiliated Hospital of Xi'an Jiaotong University), Yong Li(Baylor College of Medicine), Tianya Liu(Second Affiliated Hospital of Xi'an Jiaotong University), Qi Sun(First Affiliated Hospital of Xi'an Jiaotong University), Wenguang Yang(First Affiliated Hospital of Xi'an Jiaotong University)
Small
October 21, 2024
10.1002/smll.202404892
Cited by 6

Related Papers

Circular RNAs function as ceRNAs to regulate and control human cancer progression
|Molecular Cancer|2018|1.1k
Neoantigen vaccine: an emerging tumor immunotherapy
|Molecular Cancer|2019|718
MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program
|Blood|2013|683
Emerging role of tumor-related functional peptides encoded by lncRNA and circRNA
|Molecular Cancer|2020|578
Circular RNAs in human cancer
|Molecular Cancer|2017|527